Arabinonucleic acids: 2′-stereoisomeric modulators of siRNA activity

Nucleic Acid Therapeutics

Volumn 24, Issue 5, 2014, Pages 336-343

  Anzahaee, Maryam Yahyaee ^a   Deleavey, Glen F ^a   Le, Phuong Uyen ^b   Fakhoury, Johans ^a   Petrecca, Kevin ^b   Damha, Masad J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2' FLUORO ARABINONUCLEOTIDE; ARABINONUCLEOTIDE; DRR PROTEIN; FIREFLY LUCIFERASE; NUCLEOTIDE DERIVATIVE; RNA; SMALL INTERFERING RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG; 2'-DEOXY-2'-FLUORO-BETA-D-ARABINONUCLEIC ACID; FAM107A PROTEIN, HUMAN; LUCIFERASE; NUCLEAR PROTEIN;

ALLOSTERISM; ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG POTENCY; FEMALE; GENE SILENCING; GLIOBLASTOMA CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; STEREOISOMERISM; THERMOSTABILITY; ANTAGONISTS AND INHIBITORS; CONFORMATION; GENE EXPRESSION; GENETICS; GLIA; HIGH THROUGHPUT SCREENING; METABOLISM; PATHOLOGY; REPORTER GENE; SYNTHESIS; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ARABINONUCLEOTIDES; CELL LINE, TUMOR; GENE EXPRESSION; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LUCIFERASES; NEOPLASM PROTEINS; NEUROGLIA; NUCLEAR PROTEINS; NUCLEIC ACID CONFORMATION; RNA, SMALL INTERFERING; STEREOISOMERISM;

EID: 84907052549     PISSN: 21593337     EISSN: 21593345     Source Type: Journal    
DOI: 10.1089/nat.2014.0496     Document Type: Article

References (52)

1. Deleavey GF, JK Watts and MJ Damha. (2010). Chemical modification of siRNA. In: Current Protocols in Nucleic Acid Chemistry, Vol. 1. SL Beaucage et al., eds. John Wiley & Sons, Inc., New York, Ch 16, Unit 16.3.
2. Deleavey GF and MJ Damha. (2012). Designing chemically modified oligonucleotides for targeted gene silencing. Chem Biol 19:937-954.
3. Watts JK, GF Deleavey and MJ Damha. (2008). Chemically modified siRNA: tools and applications. Drug Discov Today 13:842-855.
4. Watts JK and DR Corey. (2012). Silencing disease genes in the laboratory and the clinic. J Pathol 226:365-379.
5. Kubo T, Z Zhelev, B Rumiana, H Ohba, K Doi and M Fujii. (2005). Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation. Org Biomolr Chem 3:3257-3259.
6. Kubo T, K Takamori, K-i Kanno, B Rumiana, H Ohba, M Matsukisono, Y Akebiyama and M Fujii. (2005). Efficient cleavage of RNA, enhanced cellular uptake, and controlled intracellular localization of conjugate DNAzymes. Bioorg Med Chem Lett 15:167-170.
7. Kubo T, M Morikawa, H Ohba and M Fujii. (2003). Synthesis of DNA-peptide conjugates by solid-phase fragment condensation. Org Lett 5:2623-2626.
8. Jackson AL, J Burchard, D Leake, A Reynolds, J Schelter, J Guo, JM Johnson, L Lim, J Karpilow, et al. (2006). Position-specific chemical modification of siRNAs reduces ''off-target'' transcript silencing. RNA 12:1197-1205.
9. Whitehead KA, JE Dahlman, RS Langer and DG Anderson. (2011). Silencing or stimulation? siRNA delivery and the immune system. Annu Rev Chem Biomol Eng 2:77-96.
10. Czauderna F, M Fechtner, S Dames, H Aygün, A Klippel, GJ Pronk, K Giese and J Kaufmann. (2003). Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31:2705-2716.
11. Amarzguioui M, T Holen, E Babaie and H Prydz. (2003). Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 31:589-595.
12. Braasch DA, S Jensen, Y Liu, K Kaur, K Arar, MA White and DR Corey. (2003). RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42:7967-7975.
13. Kenski DM, AJ Cooper, JJ Li, AT Willingham, HJ Har-ingsma, TA Young, NA Kuklin, JJ Jones, MT Cancilla, et al. (2010). Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivo. Nucleic Acids Res 38:660-671.
14. Hall AHS, J Wan, A Spesock, Z Sergueeva, BR Shaw and KA Alexander. (2006). High potency silencing by single-stranded boranophosphate siRNA. Nucleic Acids Res 34:2773-2781.
15. Wilds CJ and MJ Damha. (2000). 2'-Deoxy-2'-fluoro-β-d-arabinonucleosides and oligonucleotides (2F-ANA): synthesis and physicochemical studies. Nucleic Acids Res 28: 3625-3635.
16. Damha MJ, CJ Wilds, A Noronha, I Brukner, G Borkow, D Arion and MA Parniak. (1998). Hybrids of RNA and arabinonucleic acids (ANA and 2'F-ANA) are substrates of ribonuclease H. J Am Chem Soc 120:12976-12977.
17. Rosenberg I, JF Soler, Z Tocik, W-Y Ren, LA Ciszewski, P Kois, KW Pankiewicz, M Spassova and KA Watanabe. (1993). Synthesis of oligodeoxynucleotides containing the C-nucleoside and 2'-deoxy-2'-fluoro-ARA-nucleoside moieties by the H-phosphonate method.1,2. Nucleosides Nucleotides 12:381-401.
18. Kois P, Z Tocik, M Spassova, W-Y Ren, I Rosenberg, JF Soler and KA Watanabe. (1993). Synthesis and some properties of modified oligonucleotides. II. Oligonucleotides containing 2'-deoxy-2'-fluoro-β-D-arabinofuranosyl pyrimidine nucleosides. Nucleosides Nucleotides 12:1093-1109.
19. Watts JK and MJ Damha. (2008). 2'F-arabinonucleic acids (2F-ANA)-history, properties, and new frontiers. Can J Chem 86:641-656.
20. Watts JK and MJ Damha. (2008). ChemInform abstract: 2F-arabinonucleic acids (2'F-ANA)-history, properties, and new frontiers. ChemInform 39:45.
21. #RNA hybrid duplexes: roles of structure, pseu-dohydrogen bonding, hydration, ion uptake and flexibility. Nucleic Acids Res 38:2498-2511.
22. Dowler T, D Bergeron, A-L Tedeschi, L Paquet, N Ferrari and MJ Damha. (2006). Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro-β-d-arabinonucleic acid (FANA). Nucleic Acids Res 34:1669-1675.
23. Kalota A, L Karabon, CR Swider, E Viazovkina, M Elzagheid, MJ Damha and AM Gewirtz. (2006). 2'-Deoxy-2'-fluoro-β-d-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing. Nucleic Acids Res 34:451-461.
24. Li H, X Peng, P Leonard and F Seela. (2006). Binding of actinomycin C1 (D) and actinomin to base-modified oligonucleotide duplexes with parallel chain orientation. Bioorg Med Chem 14:4089-4100.
25. Denisov AY, AM Noronha, CJ Wilds, J-F Trempe, RT Pon, K Gehring and MJ Damha. (2001). Solution structure of an arabinonucleic acid (ANA)/RNA duplex in a chimeric hairpin: comparison with 2¢-fluoro-ANA/RNA and DNA/RNA hybrids. Nucleic Acids Res 29:4284-4293.
26. Noronha AM, CJ Wilds, C-N Lok, K Viazovkina, D Arion, MA Parniak and MJ Damha. (2000). Synthesis and biophysical properties of arabinonucleic acids (ANA): Circular dichroic spectra, melting temperatures, and ribonuclease H susceptibility of ANA$RNA hybrid duplexes. Biochemistry 39:7050-7062.
27. Deleavey GF, JK Watts, T Alain, F Robert, A Kalota, V Aishwarya, J Pelletier, AM Gewirtz, N Sonenberg and MJ Damha. (2010). Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing. Nucleic Acids Res 38:4547-4557.
28. Khvorova A, A Reynolds and SD Jayasena. (2003). Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209-216.
29. Schwarz DS, G Hutvágner, T Du, Z Xu, N Aronin and PD Zamore. (2003). Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:199-208.
30. Jinek M and JA Doudna. (2009). A three-dimensional view of the molecular machinery of RNA interference. Nature 457:405-412.
31. Wang H-W, C Noland, B Siridechadilok, DW Taylor, E Ma, K Felderer, JA Doudna and E Nogales. (2009). Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol 16:1148-1153.
32. Noland Cameron L, E Ma and Jennifer A Doudna. siRNA Repositioning for guide strand selection by human Dicer complexes. Mol Cell 43:110-121.
33. Noland CL and JA Doudna. (2013). Multiple sensors ensure guide strand selection in human RNAi pathways. RNA 19:639-648.
34. Le PU, A Angers-Loustau, RMWd Oliveira, A Ajlan, CL Brassard, A Dudley, H Brent, V Siu, G Trinh, et al. (2010). DRR drives brain cancer invasion by regulating cytoskel-etal-focal adhesion dynamics. Oncogene 29:4636-4647.
35. Dudley A, M Sater, PU Le, G Trinh, MS Sadr, J Bergeron, GF Deleavey, B Bedell, MJ Damha and K Petrecca. (2013). DRR regulates AKT activation to drive brain cancer invasion. Oncogene. doi: 10.1038/onc.2013.436. [Epub ahead of print]
36. Bellon L. (2001). Oligoribonucleotides with 2¢-O-(tert-butyldimethylsilyl) groups. In: Current protocols in nucleic acid chemistry. Vol. 1. SL Beaucage et al., eds. John Wiley & Sons, Inc., New York, Chapter 3, Unit 3.6.
37. Westmanu E and R Stromberg. (1994). Removal of f-butyldimethylsilyl protection in RNA-synthesis. Triethy-lamine trihydrofluoride (TEA, 3HF) is a more reliable alternative to tetrabutylammonium fluoride (TBAF). Nucleic Acids Res 22:2430-2431.
38. Weitzer S and J Martinez. (2007). The human RNA kinase hClp1 is active on 3[prime] transfer RNA exons and short interfering RNAs. Nature 447:222-226.
39. Rana TM. (2007). Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8:23-36.
40. Lee HY, K Zhou, AM Smith, CL Noland and JA Doudna. (2013). Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing. Nucleic Acids Res 41:6568-6576.
41. Lee HY, K Zhou, AM Smith, CL Noland and JA Doudna. (2013). Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing. Nucleic Acids Res 41:6568-6576.
42. Iijima A, R Hachisu, H Kobayashi, K Hashimoto, D Asano and H Kikuchi. (2007). Establishment of evaluation method for siRNA delivery using stable cell line carrying the lu-ciferase reporter gene. Biol Pharm Bull30:1844.
43. Lee H, AKR Lytton-Jean, Y Chen, KT Love, AI Park, ED Karagiannis, A Sehgal, W Querbes,CS Zurenko,et al. (2012). Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nano 7:389-393.
44. Lavergne T, C Baraguey, C Dupouy, N Parey, W Wuensche, G Sczakiel, J-J Vasseur and FO Debart. (2011). Synthesis and preliminary evaluation of pro-RNA 2¢-O-masked with biolabile pivaloyloxymethyl groups in an RNA interference assay. J Org Chem 76:5719-5731.
45. Giljohann DA, DS Seferos, AE Prigodich, PC Patel and CA Mirkin. (2009). Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 131:2072-2073.
46. Gong W and J-P Desaulniers. (2012). Gene-silencing properties of siRNAs that contain internal amide-bond linkages. Bioorg Med Chem Lett 22:6934-6937.
47. Hall AHS,J Wan, EE Shaughnessy, B Ramsay Shaw and KA Alexander. (2004). RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res 32:5991-6000.
48. Blidner RA, RP Hammer, MJ Lopez, SO Robinson and WT Monroe. (2007). Fully 2¢-deoxy-2¢-fluoro substituted nucleic acids induce RNA interference in mammalian cell culture. Chem Biol Drug Design 70:113-122.
49. Martín-Pintado N, M Yahyaee-Anzahaee, R Campos-Olivas, AM Noronha, CJ Wilds, MJ Damha and C González. (2012). The solution structure of double helical arabino nucleic acids (ANA and 2¢F-ANA): effect of arabinoses in duplex-hairpin interconversion. Nucleic Acids Res 40:9329-9339.
50. Watts JK, N Choubdar, K Sadalapure, F Robert, AS Wahba, J Pelletier, B Mario Pinto and MJ Damha. (2007). 2¢-Fluoro-4¢-thioarabino-modified oligonucleotides: confor-mational switches linked to siRNA activity. Nucleic Acids Res 35:1441-1451.
51. Deleavey GF, F Frank, M Hassler, S Wisnovsky, B Nagar and MJ Damha. (2013). The 5¢ binding MID domain of human argonaute2 tolerates chemically modified nucleotide analogues. Nucleic Acid Ther 23:81-87.
52. Martin-Pintado N, GF Deleavey, G Portella, R Campos-Olivas, M Orozco, MJ Damha and C González. (2013). Backbone FC-H.O hydrogen bonds in 2¢F-substituted nucleic acids. Angew Chem Int Ed Engl 52:12065-12068.